Adaptive Biotechnologies ADPT
NASDAQ ADPT
$23.95 -0.07 (-0.29%)
At close: Oct 19, 2026 · 4:00 PM EDT

Adaptive Biotechnologies (ADPT) Preferred Stock Liabilities (2018 - 2019)

Updated

Adaptive Biotechnologies' Preferred Stock Liabilities came in at $561.93 million for Q2 2019, up 0.2% from $560.67 million a year earlier and up 0.1% from the prior quarter.

Analysis

Adaptive Biotechnologies (ADPT) Preferred Stock Liabilities (2018 - 2019) Analysis & Trends

At the end of FY2018, Adaptive Biotechnologies' Preferred Stock Liabilities was $560.86 million, down 0.1% from FY2017.

  • Going back by year, Preferred Stock Liabilities was $561.33 million in FY2017.
  • Business Quant data shows ADPT's Preferred Stock Liabilities at $561.21 million (Q1 2019), $560.86 million (Q4 2018) and $560.67 million (Q3 2018) in the three quarters before Q2 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 HCA Healthcare 100.51 Bn 96.52 Bn - -
2 Natera 57.27 Bn 52.95 Bn 485.19 Mn -
3 Quest Diagnostics 26.09 Bn 24.22 Bn 1.03 Bn -
4 Labcorp Holdings 26.08 Bn 23.83 Bn 1.11 Bn -
5 Tenet Healthcare 22.29 Bn 11.30 Bn - -
6 Guardant Health 21.03 Bn 17.09 Bn 219.03 Mn -
7 Fresenius Medical Care AG 12.78 Bn 4.73 Bn 1.52 Bn -
8 BrightSpring Health Services 12.65 Bn 10.98 Bn 492.75 Mn -
9 Davita 12.13 Bn 9.34 Bn 1.16 Bn -
10 Adaptive Biotechnologies 3.82 Bn 2.82 Bn 51.39 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2019 561.93 Mn
Mar 31, 2019 561.21 Mn
Dec 31, 2018 560.86 Mn
Sep 30, 2018 560.67 Mn
Jun 30, 2018 560.67 Mn
API Access

Adaptive Biotechnologies Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=ADPT&period=max&api_key=YOUR_API_KEY